CohBar (CWBR) Competitors

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

$0.90

0.00 (0.00%)

(As of 04/19/2024 ET)

CWBR vs. CNSP, CYCC, NTBL, SLRX, HSTO, CYTO, SNOA, CMND, BPTH, and NOVN

Should you be buying CohBar stock or one of its competitors? The main competitors of CohBar include CNS Pharmaceuticals (CNSP), Cyclacel Pharmaceuticals (CYCC), Notable Labs (NTBL), Salarius Pharmaceuticals (SLRX), Histogen (HSTO), Altamira Therapeutics (CYTO), Sonoma Pharmaceuticals (SNOA), Clearmind Medicine (CMND), Bio-Path (BPTH), and Novan (NOVN). These companies are all part of the "pharmaceutical preparations" industry.

CohBar vs.

CNS Pharmaceuticals (NASDAQ:CNSP) and CohBar (NASDAQ:CWBR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, community ranking, profitability, earnings, risk, analyst recommendations and media sentiment.

: CNS Pharmaceuticals' return on equity of 0.00% beat CohBar's return on equity.
Company Net Margins Return on Equity Return on Assets
CNS Pharmaceuticals N/A -603.40% -421.35%
CohBar N/A N/A N/A
: In the previous week, CohBar had 1 more articles in the media than CNS Pharmaceuticals. MarketBeat recorded 2 mentions for CohBar and 1 mentions for CNS Pharmaceuticals. CohBar's average media sentiment score of 0.00 equaled CNS Pharmaceuticals'average media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CNS Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CohBar
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: CohBar is trading at a lower price-to-earnings ratio than CNS Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CNS Pharmaceuticals N/A N/A -$18.85M -$5.66 -0.04
CohBar N/A N/A -$12.18M -$4.36 -0.21
: 14.0% of CNS Pharmaceuticals shares are owned by institutional investors. Comparatively, 2.5% of CohBar shares are owned by institutional investors. 3.9% of CNS Pharmaceuticals shares are owned by company insiders. Comparatively, 6.5% of CohBar shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: CNS Pharmaceuticals received 28 more outperform votes than CohBar when rated by MarketBeat users. However, 72.00% of users gave CohBar an outperform vote while only 70.77% of users gave CNS Pharmaceuticals an outperform vote.
Company Underperform Outperform
CNS Pharmaceuticals Outperform Votes
46
70.77%
Underperform Votes
19
29.23%
CohBar Outperform Votes
18
72.00%
Underperform Votes
7
28.00%
: CNS Pharmaceuticals has a beta of 2.67, suggesting that its stock price is 167% more volatile than the S&P 500. Comparatively, CohBar has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CNS Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
CohBar
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Net Margins	Return on Equity	Return on Assets
CNS Pharmaceuticals	N/A	-603.40%	-421.35%
CohBar	N/A	N/A	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CNS Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CohBar	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CNS Pharmaceuticals	N/A	N/A	-$18.85M	-$5.66	-0.04
CohBar	N/A	N/A	-$12.18M	-$4.36	-0.21

Company	Underperform	Outperform
CNS Pharmaceuticals	Outperform Votes 46 70.77%	Underperform Votes 19 29.23%
CohBar	Outperform Votes 18 72.00%	Underperform Votes 7 28.00%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CNS Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
CohBar	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

CohBar beats CNS Pharmaceuticals on 7 of the 11 factors compared between the two stocks.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

Get CohBar News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CWBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CWBR vs. The Competition

Export to Excel

Metric	CohBar	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.62M	$6.11B	$4.84B	$7.43B
Dividend Yield	N/A	3.11%	2.93%	4.01%
P/E Ratio	-0.21	7.02	177.41	14.74
Price / Sales	N/A	306.22	2,450.10	81.33
Price / Cash	N/A	29.03	46.29	34.43
Price / Book	0.17	5.34	4.55	4.16
Net Income	-$12.18M	$136.36M	$103.91M	$214.20M
7 Day Performance	12.49%	-6.80%	-4.48%	-3.51%
1 Month Performance	18.37%	-9.68%	-6.66%	-5.50%
1 Year Performance	-51.59%	-5.91%	7.69%	3.53%

CohBar Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNSP CNS Pharmaceuticals	0 of 5 stars	$0.21 -16.1%	N/A	-88.6%	$2.22M	N/A	-0.04	3	Positive News Gap Down
CYCC Cyclacel Pharmaceuticals	1.2939 of 5 stars	$1.67 +6.4%	$21.00 +1,157.5%	-82.5%	$2.20M	$420,000.00	-0.06	2,018	Analyst Report News Coverage Gap Down
NTBL Notable Labs	2.8947 of 5 stars	$0.99 -16.2%	$8.00 +712.1%	N/A	$2.19M	$310,000.00	-0.27	13
SLRX Salarius Pharmaceuticals	0 of 5 stars	$0.50 flat	N/A	-73.6%	$2.16M	$1.84M	-0.11	2	Gap Down
HSTO Histogen	0 of 5 stars	$0.50 flat	N/A	-85.8%	$2.14M	$3.77M	-0.18	7	News Coverage
CYTO Altamira Therapeutics	0 of 5 stars	$1.63 -1.8%	N/A	-93.7%	$2.58M	$320,000.00	0.00	10
SNOA Sonoma Pharmaceuticals	2.1889 of 5 stars	$0.17 flat	$3.25 +1,857.8%	-85.3%	$2.59M	$13.27M	-0.17	9	Positive News
CMND Clearmind Medicine	0 of 5 stars	$1.22 -2.4%	N/A	-93.0%	$2.06M	N/A	0.00	N/A
BPTH Bio-Path	1.4767 of 5 stars	$3.02 +2.7%	$40.00 +1,224.5%	-85.2%	$2.05M	N/A	-0.07	10	Analyst Report Short Interest ↑ News Coverage Gap Down
NOVN Novan	0 of 5 stars	$0.00 flat	N/A	N/A	$2.64M	$24.71M	0.00	90

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:CWBR) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CohBar (CWBR) Competitors

CWBR vs. CNSP, CYCC, NTBL, SLRX, HSTO, CYTO, SNOA, CMND, BPTH, and NOVN

CohBar vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CWBR vs. The Competition

CohBar Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info